The Lerxs white paper says that a patient's genetic information may be incorporated without explicit patient consent because it can improve prediction.

### Why this is right The statement conflicts with the paper's data sovereignty principle. It says genetic information is to be incorporated responsibly with explicit patient consent and that data cannot be used for any purpose without purpose-specific consent. ### The concept **Data sovereignty** here means that patients retain control over how their health information is used. Permission is not treated as a one-time general approval: the paper describes purpose-specific consent that can be withdrawn. Genetic data may support more precise predictions, but its potential usefulness does not remove the consent requirement. ### The other options - **True**: This is incorrect because the white paper explicitly requires consent for use of patient data, including for artificial intelligence training. ### Terms - **Data sovereignty**: The principle that patients control how their personal health data is accessed and used. - **Genetic information**: Information about a person's DNA and related biological markers. ### Remember Potential predictive value does not replace informed, purpose-specific consent.